Home/Pipeline/ACD-201

ACD-201

Moderate-to-Severe Crohn's Disease

Phase 1Planned

Key Facts

Indication
Moderate-to-Severe Crohn's Disease
Phase
Phase 1
Status
Planned
Company

About Advanced Cellular Dynamics

Advanced Cellular Dynamics is pioneering a new class of engineered cellular therapeutics focused on immune modulation and targeted cancer treatment. The company's core technology enables precise control over cell fate and function, aiming to create more persistent and potent therapies. With a pipeline advancing through early clinical development, ACD is positioned at the forefront of the next wave of cell therapy innovation. The company is backed by leading life science investors and maintains strategic research collaborations with academic institutions.

View full company profile